Interactive Omics of HepB Vaccine Response in Co-Infection with Parasites
Interactive Omics of HepB Vaccine Response in Co-Infection with Parasites
批准号:
9751732
负责人:
Elias K Haddad
金额:
$16.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdjuvantAdultAffinityAnimal ModelAnti-inflammatoryAntibodiesAntibody titer measurementAttenuatedAutoimmune DiseasesB-LymphocytesBCG VaccineBiodiversityCellsCellular AssayCellular ImmunityChildChronicClinicalCold ChainsComplement ActivationEbola virusEducationEvolutionExpression ProfilingFailureGene Expression ProfilingHIV/TBHelminthsHepatitis B VaccinationHumanHumoral ImmunitiesHypersensitivityImmuneImmune responseImmune systemImmunityImmunologicsImmunosuppressive AgentsImpairmentIndividualInfectionInflammatoryInflammatory Bowel DiseasesInterferon Type IIInterferonsInterleukin-10Interleukin-13Interleukin-5KineticsLinkMemory B-LymphocyteModificationParasitemiaParasitesParasitic infectionPhagocytosisPhenotypePlacebosPredispositionProcessProductionProteinsRegulationRoleSerologic testsShapesStructureSystemT-LymphocyteTetanus ToxoidTranscriptional RegulationTransforming Growth FactorsVaccinationVaccine DesignVaccinesVertebral columnantigen bindingco-infectioncytokineglycosylationhelminth infectionhuman modelimmune functionimmunoregulationimprovedinfluenza virus vaccinemacrophagemouse modelneutralizing antibodynovelnovel vaccinespathogenpreventresponsetoolvaccine effectivenessvaccine efficacyvaccine responsevaccine-induced immunityyoung adult
中文摘要
项目摘要
尽管我们的临床批准疫苗工具包越来越多,可以预防数百万人的生命
每年,疫苗在全球的有效性并不相同,尤其是低
发展中国家的覆盖率。在疫苗的潜在贡献者中
发展中国家的失败、可获得性、冷链断裂和教育
被认为是疫苗有效性的结构性障碍。然而,新兴的
在人类和动物模型中的证据都表明寄生虫感染的关键作用
作为疫苗诱导免疫的免疫学混杂因子。具体地说,寄生虫感染
世界上超过三分之一的地区,经过数千年的进化,与他们的
主持人。为了实现共存,寄生虫进化出了免疫抑制策略
这极大地改变了宿主的免疫系统。这些更改包括增强版
抗炎细胞因子表达谱和扭曲的T辅助细胞(Th)免疫
共同牵涉到对新感染和新感染的反应受损
接种疫苗。然而,寄生虫感染对改变的抗体免疫的影响
更具争议性,寄生虫感染与总体减少有关
有些疫苗可以检测抗体效价,但其他疫苗则不能。然而,鉴于Th的关键作用
免疫编程的体液反应,这是看似合理的,虽然寄生
感染可能只会可变地改变体液免疫反应的总体大小,
这些免疫变化可能会对塑造人类免疫系统的质量产生巨大影响
体液免疫反应。因此,在这个项目下,我们的目标是全面
剖析寄生虫混合感染对改变和塑造人类免疫功能状态的影响
疫苗诱导的记忆B细胞反应及其功能特征
疫苗诱导的抗体。
英文摘要
Project Abstract
Despite our growing tool kit of clinically approved vaccines that prevent millions of lives
annually, vaccine effectiveness is not equivalent across the globe, with particularly low
coverage rates in the developing world. Among the potential contributors to vaccine
failures in the developing world, accessibility, cold chain breaks, and education have
been implicated as structural barriers to vaccine effectiveness. However, emerging
evidence both in humans and animal models point to a critical role of parasitic infections
as immunological confounders of vaccine induced immunity. Specifically, parasites infect
more than a third of the world and have evolved over millennia to co-exist with their
hosts. To achieve co-existence, parasites have evolved immunosuppressive strategies
that dramatically alter the host’s immune system. These alterations include enhanced
anti-inflammatory cytokine expression profiles and skewed T-helper (Th) immunity that
collectively have been implicated in impaired response to both de novo infections and
vaccination. However, the impact of parasitic infections on altered antibody immunity has
been more controversial, where parasitic infection has been linked to reduced overall
antibody titers in some vaccines but not others. However, given the critical role of Th
immunity in programming the humoral response, it is plausible that while parasitic
infection may only alter the overall magnitude of the humoral immune response variably,
that these immunologic changes may have a dramatic impact on shaping the quality of
the humoral immune response. Thus under this project we aim to comprehensively
dissect the impact of parasitic co-infection on altering and shaping both the state of the
vaccine induced memory B cell response as well as the functional character of the
vaccine induced antibodies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interactive Omics of HepB Vaccine Response in Co-Infection with Parasites
-
批准号:10163554
-
项目类别:
-
资助金额:$54.11万
-
财政年份:2020
-
负责人:Elias K Haddad
-
依托单位:
Administrative Core: Core A
-
批准号:10224802
-
项目类别:
-
资助金额:$2.03万
-
财政年份:2017
-
负责人:Elias K Haddad
-
依托单位:
Integrative Omics of HepB Vaccine Response in Co-Infection with Parasites
-
批准号:10224801
-
项目类别:
-
资助金额:$76.12万
-
财政年份:2017
-
负责人:Elias K Haddad
-
依托单位:
Integrative Omics of HepB Vaccine Response in Co-Infection with Parasites
-
批准号:10246591
-
项目类别:
-
资助金额:$177.91万
-
财政年份:2017
-
负责人:Elias K Haddad
-
依托单位:
Integrative Omics of HepB Vaccine Response in Co-Infection with Parasites
-
批准号:9751727
-
项目类别:
-
资助金额:$76.88万
-
财政年份:2017
-
负责人:Elias K Haddad
-
依托单位:
Interactive Omics of HepB Vaccine Response in Co-Infection with Parasites
-
批准号:10224805
-
项目类别:
-
资助金额:$23.16万
-
财政年份:2017
-
负责人:Elias K Haddad
-
依托单位:
Boosting anti-HIV immunity through manipulation of Tfh function.
-
批准号:8848340
-
项目类别:
-
资助金额:$55.1万
-
财政年份:2013
-
负责人:Elias K Haddad
-
依托单位:
Boosting anti-HIV immunity through manipulation of Tfh function.
-
批准号:9272789
-
项目类别:
-
资助金额:$54.63万
-
财政年份:2013
-
负责人:Elias K Haddad
-
依托单位:
Boosting anti-HIV immunity through manipulation of Tfh function.
-
批准号:8603328
-
项目类别:
-
资助金额:$52.42万
-
财政年份:2013
-
负责人:Elias K Haddad
-
依托单位:
Administrative Core: Core A
-
批准号:9751729
-
项目类别:
-
资助金额:$7.32万
-
财政年份:--
-
负责人:Elias K Haddad
-
依托单位:
Administrative Core: Core A
-
批准号:9542194
-
项目类别:
-
资助金额:$7.74万
-
财政年份:--
-
负责人:Elias K Haddad
-
依托单位:
海外基金